TOKYO GAS Co., Ltd.: Action Policy Toward Continuous Corporate Value Enhancement
TOKYO, March 26, 2025 /PRNewswire/ -- FY25 marks our 140th anniversary and the final year of our current Medium-Term Management Plan (MTMP). As we reach this milestone, we are reaffirming our commitment to continuous corporate value enhancement....
Kelun-Biotech's Radionuclide-Drug Conjugate (RDC) SKB107 Receives NMPA Approval For The Treatment of Bone Metastases in Solid Tumors
CHENGDU, China, March 26, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company has received a clinical trial notice approving the investigational new drug application for a...
HMS for Car Builds In-Vehicle Ecosystem with Southeast Asian Partners
BANGKOK, March 25, 2025 /PRNewswire/ -- Huawei's HMS for Car showcased innovations at the Bangkok International Motor Show, highlighting upgrades to its MAAN3.0 architecture (MAP BOX, AI BOX, APP BOX, NET BOX) and localized collaborations to advance...
LightInTheBox Reports Fourth Quarter and Full Year 2024 Financial Results
SINGAPORE, March 25, 2025 /PRNewswire/ -- LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), a global specialty retailer focusing on proprietary apparel brands and design-driven collections tailored to evolving consumer...
ANO-NE Kids Club to Open in Ginza, Japan on April 1: Safe "Playcation" for Kids, Carefree Time for Parents
TOKYO, March 25, 2025 /PRNewswire/ -- ANO-NE Kids Club, an innovative indoor play facility providing short-term childcare, will open in Tokyo's Ginza district on April 1, 2025. Developed by Cosmos Hotel Management Co., Ltd. and COSMOS INITIA Co.,...
FOR SALE BY EXPRESSION OF INTEREST: FREEHOLD CONSERVATION SHOPHOUSE WITH RARE F&B APPROVAL AT 350/350A TANJONG KATONG ROAD
SINGAPORE, March 25, 2025 /PRNewswire/ -- Brilliance Capital Pte. Ltd. is pleased to present an exceptional opportunity to acquire a freehold conservation two-storey shophouse with an attic at 350/350A Tanjong Katong Road. This rare offering is...
Sungen Biomedical's world-first new drug SGC001 monoclonal antibody receives FDA fast track approval
NEW YORK, March 24, 2025 /PRNewswire/ -- On March 17, 2025, US time, the world's first acute myocardial infarction (AMI) antibody drug, SGC001, developed by Sungen Biomedical—an innovative biopharmaceutical company incubated by Beijing Hotgen...
SineuGene Therapeutics Announces FDA IND Clearance for SNUG01, a First-in-Class TRIM72-Targeted Gene Therapy for ALS
BEIJING, March 24, 2025 /PRNewswire/ -- SineuGene Therapeutics Co., Ltd. ("SineuGene"), a clinical-stage biotech company pioneering innovative therapies for neurological disorders, today announced that the U.S. Food and Drug Administration (FDA) has...
ArkBio Announces the Completion of Phase III Clinical Study for AK0901 in the Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in China
SHANGHAI, March 24, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the successful completion of the Phase III clinical study of AK0901, a novel drug for the treatment of attention deficit hyperactivity...
AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development Accelerates
HONG KONG, March 24, 2025 /PRNewswire/ -- AIM Vaccine Co., Ltd. (06660.HK), a leading PRC vaccine company, published an announcement on March 23, 2025, the company's independently developed mRNA shingles vaccine has recently received clinical trial...